Methods for detecting membrane derived caspase activity and modulators thereof
CA 2366918 A1 · Owner: Idun Pharmaceuticals, Inc. · Inventors: Krebs, Joseph F.; Fritz, Lawrence C.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Provided are methods for detecting membrane derived apoptotic activity. In one embodiment, the present invention provides methods for identifying membrane derived caspase activity. In other embodiments drug discovery methods are , provided for screening compounds that inhibit or enhance membrane derived caspase activity. In the various embodiments heavy membrane fractions are , utilized for the screening methodologies described herein.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 6, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended March 6, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 6, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.